FR9F - Applications thérapeutiques de l'arginase (corps 45-25c). - Google Patents

Applications thérapeutiques de l'arginase (corps 45-25c).

Info

Publication number
FR9F
FR9F FR856409A FR856409A FR9F FR 9 F FR9 F FR 9F FR 856409 A FR856409 A FR 856409A FR 856409 A FR856409 A FR 856409A FR 9 F FR9 F FR 9F
Authority
FR
France
Prior art keywords
arginase
therapeutic applications
therapeutic
applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR856409A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A CASTAIGNE LAB
Original Assignee
A CASTAIGNE LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR832639A external-priority patent/FR53M/fr
Priority claimed from FR851463A external-priority patent/FR8F/fr
Application filed by A CASTAIGNE LAB filed Critical A CASTAIGNE LAB
Priority to FR856409A priority Critical patent/FR9F/fr
Application granted granted Critical
Publication of FR9F publication Critical patent/FR9F/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/50Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR856409A 1960-07-11 1961-03-22 Applications thérapeutiques de l'arginase (corps 45-25c). Expired FR9F (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR856409A FR9F (fr) 1960-07-11 1961-03-22 Applications thérapeutiques de l'arginase (corps 45-25c).

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR832639A FR53M (fr) 1960-07-11 1960-07-11 Applications thérapeutiques de l'arginase corps (45-25c)
FR851463A FR8F (fr) 1960-07-11 1961-02-02 Applications thérapeutiques de l'arginase corps 45-25c.
FR856409A FR9F (fr) 1960-07-11 1961-03-22 Applications thérapeutiques de l'arginase (corps 45-25c).

Publications (1)

Publication Number Publication Date
FR9F true FR9F (fr) 1962-03-09

Family

ID=1341454

Family Applications (1)

Application Number Title Priority Date Filing Date
FR856409A Expired FR9F (fr) 1960-07-11 1961-03-22 Applications thérapeutiques de l'arginase (corps 45-25c).

Country Status (1)

Country Link
FR (1) FR9F (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022235796A1 (fr) 2021-05-07 2022-11-10 Baylor College Of Medicine Traitement de l'ostéogenèse imparfaite modérée à sévère

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022235796A1 (fr) 2021-05-07 2022-11-10 Baylor College Of Medicine Traitement de l'ostéogenèse imparfaite modérée à sévère

Similar Documents

Publication Publication Date Title
OA01009A (fr) Préparation d'urée.
FR1131M (fr) Utilisation d'une gaze en polyoléfine.
FR1137M (fr) Applications thérapeutiques de cyclohexyl-phénols.
CH419606A (fr) Composition polymérisable et utilisation de cette composition
BE606638A (fr) Orotate de lysine et ses applications thérapeutiques
FR9F (fr) Applications thérapeutiques de l'arginase (corps 45-25c).
FR8F (fr) Applications thérapeutiques de l'arginase corps 45-25c.
FR53M (fr) Applications thérapeutiques de l'arginase corps (45-25c)
FR1280912A (fr) Gaine élastique de maintien du corps
FR1262699A (fr) Raccord d'éléments de canalisations
FR1289913A (fr) Extracteur de corps en solution
FR1309179A (fr) Polymérisation de l'acrylonitrile
BE603309A (fr) Corps compound
FR1275646A (fr) Robinet d'arrêt
FR1247653A (fr) Soupape et corps de soupape
FR78127E (fr) Règle médicale
FR1286578A (fr) Corps abrasif
FR1273164A (fr) Corps de soupape
FR1276779A (fr) Isolement de la 4, 4'-dihydroxy-diphénylsulfone de mélanges de ce corps avec l'isomère 2, 4'-dihydroxy-diphénylsulfone
FR1316323A (fr) Corps de projectile
FR1321074A (fr) Polymérisation de l'isoprène
CA603285A (en) Treatment of rayon
AU258585B2 (en) Improvements inthe treatment of polyethylene
BE616246A (fr) Préparation de l'octafluorocyclobutane
AU260857B2 (en) Improvements inthe treatment of liquids